Overview

Patient Experience Study of Deoxycholic Acid Injection

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to determine the safety of deoxycholic acid subcutaneous (SC) injections in the submental area and to evaluate the effects of four interventions, relative to placebo in the submental area, particularly with regard to assessment and management of pain, bruising, and swelling/edema.
Phase:
Phase 3
Details
Lead Sponsor:
Kythera Biopharmaceuticals
Treatments:
Anti-Inflammatory Agents
Deoxycholic Acid
Epinephrine
Epinephryl borate
Ibuprofen
Lidocaine
Loratadine
Racepinephrine